Answers are grounded in this paper and cite their sources.
Escitalopram did not reduce AF burden; leaves open whether SSRIs modulate arrhythmia risk via autonomic effects in comorbid depression.
BACKGROUND: Atrial fibrillation and depression are frequently comorbid, with autonomic dysfunction as a potential shared underlying pathophysiology. However, the effect of the treatment of depression on atrial fibrillation has not been well characterized, despite previous investigation of selective serotonin reuptake inhibitors into other forms of cardiovascular disease such as coronary artery disease. OBJECTIVE: To test whether escitalopram, a selective serotonin reuptake inhibitor, reduces AF-related symptoms, AF burden and AF presentations to hospital compared to placebo, in addition to standard of care. METHODS: Multicenter, randomized, single-blind, parallel-group superiority trial. Eligible participants are aged 18-80 years with paroxysmal or persistent atrial fibrillation, with the goal of rhythm control, who also score 8 or more on the PHQ-9 questionnaire (out of a maximum score of 27). 154 patients will be randomized to escitalopram or placebo in doses of 5mg to 20mg, titrated to individual patient response. The primary outcome is the Atrial Fibrillation Effect on Quality of Life (AFEQT) score. Secondary outcomes include AF burden, adherence to lifestyle risk factor management including self-rated physical activity index (EPIC-PAQ-S questionnaire), general quality of life (SF-36 questionnaire), and hospital presentations for atrial fibrillation. Rhythm monitoring for AF burden will be undertaken with either mobile single lead ECG monitoring (Alivecor Kardiamobile), ECG-capable smartwatch, Holter monitoring or interrogation of pre-existing cardiac electronic implantable device. Autonomic metrics will be assessed by non-invasive recordings of blood pressure and heart rate variability. CONCLUSIONS: The study aims to determine the impact of managing AF with a selective serotonin reuptake inhibitor, with a patient-centered primary outcome.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: